Journey Medical (DERM) EPS (Weighted Average and Diluted): 2020-2025
Historic EPS (Weighted Average and Diluted) for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to -$0.09.
- Journey Medical's EPS (Weighted Average and Diluted) rose 25.00% to -$0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.35, marking a year-over-year increase of 62.77%. This contributed to the annual value of -$0.72 for FY2024, which is 242.86% down from last year.
- According to the latest figures from Q3 2025, Journey Medical's EPS (Weighted Average and Diluted) is -$0.09, which was up 43.75% from -$0.16 recorded in Q2 2025.
- Journey Medical's EPS (Weighted Average and Diluted)'s 5-year high stood at $0.80 during Q3 2023, with a 5-year trough of -$1.89 in Q4 2021.
- For the 3-year period, Journey Medical's EPS (Weighted Average and Diluted) averaged around -$0.14, with its median value being -$0.16 (2025).
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first slumped by 921.74% in 2021, then skyrocketed by 240.35% in 2023.
- Journey Medical's EPS (Weighted Average and Diluted) (Quarterly) stood at -$1.89 in 2021, then surged by 68.25% to -$0.60 in 2022, then spiked by 80.00% to -$0.12 in 2023, then spiked by 166.67% to $0.08 in 2024, then increased by 25.00% to -$0.09 in 2025.
- Its last three reported values are -$0.09 in Q3 2025, -$0.16 for Q2 2025, and -$0.18 during Q1 2025.